These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 33231535

  • 1. Development of Rift valley fever encephalitis in rats is mediated by early infection of olfactory epithelium and neuroinvasion across the cribriform plate.
    Boyles DA, Schwarz MM, Albe JR, McMillen CM, O'Malley KJ, Reed DS, Hartman AL.
    J Gen Virol; 2021 Feb; 102(2):. PubMed ID: 33231535
    [Abstract] [Full Text] [Related]

  • 2. Vascular permeability in the brain is a late pathogenic event during Rift Valley fever virus encephalitis in rats.
    Walters AW, Kujawa MR, Albe JR, Reed DS, Klimstra WB, Hartman AL.
    Virology; 2019 Jan 02; 526():173-179. PubMed ID: 30396029
    [Abstract] [Full Text] [Related]

  • 3. Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model.
    Dodd KA, McElroy AK, Jones TL, Zaki SR, Nichol ST, Spiropoulou CF.
    PLoS Negl Trop Dis; 2014 Jun 02; 8(6):e2874. PubMed ID: 24922480
    [Abstract] [Full Text] [Related]

  • 4. Choice of inbred rat strain impacts lethality and disease course after respiratory infection with Rift Valley Fever Virus.
    Bales JM, Powell DS, Bethel LM, Reed DS, Hartman AL.
    Front Cell Infect Microbiol; 2012 Jun 02; 2():105. PubMed ID: 22919694
    [Abstract] [Full Text] [Related]

  • 5. Neutrophil and macrophage influx into the central nervous system are inflammatory components of lethal Rift Valley fever encephalitis in rats.
    Albe JR, Boyles DA, Walters AW, Kujawa MR, McMillen CM, Reed DS, Hartman AL.
    PLoS Pathog; 2019 Jun 02; 15(6):e1007833. PubMed ID: 31220182
    [Abstract] [Full Text] [Related]

  • 6. Rift Valley Fever Virus Encephalitis: Viral and Host Determinants of Pathogenesis.
    Wilson LR, McElroy AK.
    Annu Rev Virol; 2024 Sep 02; 11(1):309-325. PubMed ID: 38635867
    [Abstract] [Full Text] [Related]

  • 7. Identification and Characterization of Rift Valley Fever Virus-Specific T Cells Reveals a Dependence on CD40/CD40L Interactions for Prevention of Encephalitis.
    Barbeau DJ, Cartwright HN, Harmon JR, Spengler JR, Spiropoulou CF, Sidney J, Sette A, McElroy AK.
    J Virol; 2021 Nov 09; 95(23):e0150621. PubMed ID: 34495703
    [Abstract] [Full Text] [Related]

  • 8. Rift Valley Fever Virus Infection Causes Acute Encephalitis in the Ferret.
    Barbeau DJ, Albe JR, Nambulli S, Tilston-Lunel NL, Hartman AL, Lakdawala SS, Klein E, Duprex WP, McElroy AK.
    mSphere; 2020 Oct 28; 5(5):. PubMed ID: 33115835
    [Abstract] [Full Text] [Related]

  • 9. Limiting viral replication in hepatocytes alters Rift Valley fever virus disease manifestations.
    Xu L, Paine AC, Barbeau DJ, Alencastro F, Duncan AW, McElroy AK.
    J Virol; 2023 Sep 28; 97(9):e0085323. PubMed ID: 37695055
    [Abstract] [Full Text] [Related]

  • 10. Peripheral Blood Biomarkers of Disease Outcome in a Monkey Model of Rift Valley Fever Encephalitis.
    Wonderlich ER, Caroline AL, McMillen CM, Walters AW, Reed DS, Barratt-Boyes SM, Hartman AL.
    J Virol; 2018 Feb 01; 92(3):. PubMed ID: 29118127
    [Abstract] [Full Text] [Related]

  • 11. Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.
    Scharton D, Bailey KW, Vest Z, Westover JB, Kumaki Y, Van Wettere A, Furuta Y, Gowen BB.
    Antiviral Res; 2014 Apr 01; 104():84-92. PubMed ID: 24486952
    [Abstract] [Full Text] [Related]

  • 12. Rift Valley Fever Virus Infects the Posterior Segment of the Eye and Induces Inflammation in a Rat Model of Ocular Disease.
    Schwarz MM, Connors KA, Davoli KA, McMillen CM, Albe JR, Hoehl RM, Demers MJ, Ganaie SS, Price DA, Leung DW, Amarasinghe GK, McElroy AK, Reed DS, Hartman AL.
    J Virol; 2022 Oct 26; 96(20):e0111222. PubMed ID: 36194021
    [Abstract] [Full Text] [Related]

  • 13. The pathogenesis of Rift Valley fever virus in the mouse model.
    Smith DR, Steele KE, Shamblin J, Honko A, Johnson J, Reed C, Kennedy M, Chapman JL, Hensley LE.
    Virology; 2010 Nov 25; 407(2):256-67. PubMed ID: 20850165
    [Abstract] [Full Text] [Related]

  • 14. Advances in Understanding Neuropathogenesis of Rift Valley Fever Virus.
    Connors KA, Hartman AL.
    Annu Rev Virol; 2022 Sep 29; 9(1):437-450. PubMed ID: 36173701
    [Abstract] [Full Text] [Related]

  • 15. The NSs Protein Encoded by the Virulent Strain of Rift Valley Fever Virus Targets the Expression of Abl2 and the Actin Cytoskeleton of the Host, Affecting Cell Mobility, Cell Shape, and Cell-Cell Adhesion.
    Bamia A, Marcato V, Boissière M, Mansuroglu Z, Tamietti C, Romani M, Simon D, Tian G, Niedergang F, Panthier JJ, Flamand M, Souès S, Bonnefoy E.
    J Virol; 2020 Dec 09; 95(1):. PubMed ID: 33087469
    [Abstract] [Full Text] [Related]

  • 16. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Terasaki K, Tercero BR, Makino S.
    Virus Res; 2016 May 02; 216():55-65. PubMed ID: 26022573
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.